TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Principal Technologies ( (TSE:PTEC) ) is now available.
Principal Technologies Inc. has secured a financing agreement with RLOX Beteiligung GmbH to support its Licence of Technology Agreement with Oxford University Innovation Limited. The funding, totaling C$3,744,000, will be used for research and development in skin cancer detection technology and other corporate purposes. This strategic move allows Principal to hold a 50% interest in the net profits from the developed medical technology products, potentially strengthening its position in the healthcare technology industry.
More about Principal Technologies
Principal Technologies Inc. is a Canadian-based healthcare acquisition company focused on building a portfolio of profitable healthcare technology companies. The company emphasizes global distribution potential and intellectual property that enhances medical treatment quality, cost efficiency, patient pathway optimization, and point-of-care technologies.
YTD Price Performance: 36.36%
Average Trading Volume: 212,442
Technical Sentiment Signal: Sell
Current Market Cap: C$8.45M
For an in-depth examination of PTEC stock, go to TipRanks’ Stock Analysis page.